Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them

Details for Australian Patent Application No. 2002223631 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Heitsch, Holger; Englert, Heinrich Christian

Agent Watermark

Pub. Number AU-B-2002223631

PCT Pub. Number WO02/36565

Priority 10054482 03.11.00 DE

Filing date 20 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 6 July 2006

International Classifications

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 333/24 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

6 July 2006 Application Accepted

  Published as AU-B-2002223631

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002223632

2002223630